Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5).

Document type:: Journal Article; Letter
Author(s):: Schuler, E; Giagounidis, A; Haase, D; Shirneshan, K; Büsche, G; Platzbecker, U; Nolte, F; Götze, K; Schlenk, R F; Ganser, A; Letsch, A; Braulke, F; Lübbert, M; Bug, G; Schafhausen, P; Bacher, U; Gattermann, N; Wulfert, M; Haas, R; Germing, U
Title:: Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5).
Journal title abbreviation:: Leukemia
Year:: 2016
Journal volume:: 30
Journal issue:: 7
Pages contribution:: 1580-2
Language:: eng
Fulltext / DOI:: doi:10.1038/leu.2015.340
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/26668126
Print-ISSN:: 0887-6924
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: